European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis.

The Task Force for the management of COVID-19, of the European Society of Cardiology (2022). European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis. Cardiovascular research, 118(6), pp. 1385-1412. Oxford University Press 10.1093/cvr/cvab342

[img] Text
ESC.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (6MB)

AIMS

Since its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the globe. The aim of this two-part series is to provide practical knowledge and guidance to aid clinicians in the diagnosis and management of cardiovascular disease (CVD) in association with COVID-19.

METHODS AND RESULTS

A narrative literature review of the available evidence has been performed, and the resulting information has been organized into two parts. The first, reported here, focuses on the epidemiology, pathophysiology, and diagnosis of cardiovascular (CV) conditions that may be manifest in patients with COVID-19. The second part, which will follow in a later edition of the journal, addresses the topics of care pathways, treatment, and follow-up of CV conditions in patients with COVID-19.

CONCLUSION

This comprehensive review is not a formal guideline but rather a document that provides a summary of current knowledge and guidance to practicing clinicians managing patients with CVD and COVID-19. The recommendations are mainly the result of observations and personal experience from healthcare providers. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0008-6363

Publisher:

Oxford University Press

Language:

English

Submitter:

Nadia Biscozzo

Date Deposited:

20 Jan 2022 08:29

Last Modified:

08 May 2022 00:12

Publisher DOI:

10.1093/cvr/cvab342

PubMed ID:

34864874

Additional Information:

The Task Force for the management of COVID-19 of the European Society of Cardiology: Stephan Windecker

Uncontrolled Keywords:

ACE2 Arrhythmias Biomarkers COVID-19 Cardiogenic shock Myocardial injury Myocarditis Non-invasive imaging

BORIS DOI:

10.48350/163174

URI:

https://boris.unibe.ch/id/eprint/163174

Actions (login required)

Edit item Edit item
Provide Feedback